Strategically merged into Bestat Group. This integration enables a full-service portfolio bridging preclinical R&D to clinical development.
Corporate Overview
Founded in March 2014, Trifecta MedTek has dedicated over a decade to excellence in analytical testing and pre-clinical R&D. With rigorous science at our core, we have established an integrated platform encompassing pharmaceutical analysis, pharmacology research, toxicology assessment, and antibody process development.
As a strategic R&D partner, Trifecta MedTek provides comprehensive CRO services across diverse modalities, including small molecules, antibodies, exosomes, and cell therapy products, with the technical capacity to support clinical bioanalysis. By leveraging our multidisciplinary technical team, state-of-the-art instrumentation, robust quality management systems, and strict regulatory compliance (GLP, ISO/IEC 17025), we empower clients to maintain precise control over research data and quality throughout the critical transition from early development to clinical translation—accelerating the “Bench-to-Market” commercialization process.
Corporate Overview
Founded in March 2014, Trifecta MedTek (TMT) has dedicated over a decade to excellence in analytical testing and pre-clinical R&D. With rigorous science at our core, we have established an integrated platform encompassing pharmaceutical analysis, pharmacology research, toxicology assessment, and antibody process development.
As a strategic R&D partner, TMT provides comprehensive CRO services across diverse modalities, including small molecules, antibodies, exosomes, and cell therapy products, with the technical capacity to support clinical bioanalysis. By leveraging our multidisciplinary technical team, state-of-the-art instrumentation, robust quality management systems, and strict regulatory compliance (GLP, ISO/IEC 17025), we empower clients to maintain precise control over research data and quality throughout the critical transition from early development to clinical translation—accelerating the “Bench-to-Market” commercialization process.
Corporate Milestones
Quality & Certifications
Trifecta MedTek is committed to premium contract research services adhering to international regulatory standards. We have established a robust quality management system to deliver precise analytical testing for food, pharmaceuticals, and biological samples (including clinical specimens), alongside high-quality non-clinical CRO services. We ensure every data point possesses rigorous regulatory traceability, assisting our partners in generating globally recognized reports to advance their international R&D and clinical milestones.
Laboratory Accreditations
Taiwan Accreditation Foundation (TAF)
- OECD GLP Compliance Monitoring Program (Registration No.: GLP0031)
- ISO/IEC 17025 Testing Laboratory (Accreditation No.: 3033)
Taiwan Food and Drug Administration (TFDA)
- GLP Compliance Program (Certificate No.: GLP1120001)